Elicera Therapeutics AB (publ) (STO:ELIC)
2.465
+0.025 (1.02%)
Nov 20, 2026, 5:25 PM CET
Elicera Therapeutics AB Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Elicera Therapeutics AB stock has an average price target of krĀ 7.30. The average 1-year stock price forecast is 196.15% higher than the current stock price, while the lowest is krĀ 6.50 (+163.69%) and the highest is krĀ 8.00 (+224.54%).
Price Target: krĀ 7.30 (+196.15%)
Analyst Consensus: n/a
Price Target
ChartAnalyst Ratings
There are currently no analyst ratings available for Elicera Therapeutics AB.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0 | 0 | 0 | 0 | 0 | 0 |
Financial Forecast
Revenue This Year
1.60M
from 10.86M
Decreased by -85.26%
Revenue Next Year
29.97M
from 1.60M
Increased by 1,772.92%
EPS This Year
-0.47
from -0.38
EPS Next Year
-0.51
from -0.47
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SEK.